Familial Hypercholesterolemia: Clinical Trials

6 trials for Familial Hypercholesterolemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting. 6 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 5, Not yet recruiting 1
Phase 21Completed 1

Follow Familial Hypercholesterolemia: new trials by email Literature Review of Familial Hypercholesterolemia trials Research Report on Familial Hypercholesterolemia

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers
VSA003, 0.9% NaCl - Dyslipidemias, Familial Hypercholesterolemia
Phase 1CompletedVisirna Therapeutics HK Limited362023-06-012025-09-12
Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH
Low Density Lipoprotein Receptor mRNA Exosomes - Familial Hypercholesterolemia
Phase 1Not yet recruitingTang-Du Hospital302021-12-012021-09-14
Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients
ARO-ANG3, sterile normal saline (0.9% NaCl) - Dyslipidemias, Familial Hypercholesterolemia
Phase 1CompletedArrowhead Pharmaceuticals932019-01-072025-12-24
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Participants With Familial Hypercholesterolemia
IONIS ANGPTL3-LRx, Placebo - Hypertriglyceridemia, Familial Hypercholesterolemia
Phase 1CompletedIonis Pharmaceuticals, Inc.482015-11-302020-11-19
Efficacy of a New Symbiotic Formulation in Children With Familial Hypercholesterolemia
Lactobacillus paracasei B21060, low satured diet - Dyslipidemia, Familial Hypercholesterolemia
Phase 1 / Phase 2CompletedFederico II University402012-01-012014-01-29
Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia
gene therapy - Familial Hypercholesterolemia
Phase 1CompletedNational Center for Research Resources (NCRR)51992-06-012005-06-24

Narrower conditions

Hyperlipoproteinemia Type II (6)  ·  Dyslipidemias (3)  ·  Hypertriglyceridemia (3)  ·  Metabolism, Inborn Errors (1)  ·  Rare Diseases (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Genetic Diseases, Inborn (6)  ·  Hyperlipidemias (6)  ·  Hyperlipoproteinemias (6)  ·  Lipid Metabolism Disorders (6)  ·  Lipid Metabolism, Inborn Errors (6)  ·  Metabolic Diseases (6)  ·  Nutritional and Metabolic Diseases (6)  ·  Metabolism, Inborn Errors (5)  ·  Dyslipidemias (3)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Genetic Therapy (1)  ·  IONIS-ANGPTL3-LRx (1)  ·  Saline Solution (1)

Sponsors

Arrowhead Pharmaceuticals (1)  ·  Federico II University (1)  ·  Ionis Pharmaceuticals, Inc. (1)  ·  National Center for Research Resources (NCRR) (1)  ·  Tang-Du Hospital (1)  ·  Visirna Therapeutics HK Limited (1)

Countries

China (2)  ·  Australia (1)  ·  Canada (1)  ·  New Zealand (1)

Top investigators

James M. Wilson (1)  ·  Lijun Yuan (1)

Results publications

PMID 28538111, PMID 33900278, PMID 37626170, PMID 41946917

NIH funding

2015 (1)